Featured

Feature: Nigerian Gets CRI Recognition For Cancer Cure

Published

6 years ago

August 28, 2019

Nigeria has lost several persons, including well-known and admirable personalities to cancer. This list includes former Director-General, DG of the National Institute of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof. Dora Akunyili; former First Lady, Hajiya Mariam Babangida; wife of former Managing Director of the Niger Delta Development Commission, NDDC, Aliere Alaibe, and legal icon and human rights activist, Gani Fawehinmi (SAN). Some say the death of these highly placed individuals acted as some form of wake up call to Nigeria that indeed cancer is silently killing many of its citizens.

A first and obvious breakthrough was recorded when on August 16, the Cancer Research Institute, CRI, a non-profit organisation founded in the United States of America in1953 and dedicated exclusively to advancing immunotherapy to treat, control, and cure all cancers wrote to a Nigerian researcher, Ben Amodu, recognising the fact that his research has the potentials to change the narrative in cancer cure.

“We believe your research has the potential to change many lives for the wellbeing of millions suffering especially in Africa where it (cancer) is prevalent. We also believe your products can qualify for our $175,000 Immunotherapy advancement Grant for immunotherapy which is geared at propelling such meticulous research into full-blown treatments available for disbursements” the NCI stated.

The NCI is requesting letters of intent for its Clinic and Laboratory Integration Programme, CLIP, offering grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Cancer has become a huge menace in today’s society. The name cancer is now associated with death. The treatment is usually expensive, in addition to other side effects. For instance, ‘Chemotherapy’ is not only painful but causes loss of hair. It is a system whereby drugs are injected into the patients’ veins. October has been tagged as the ‘breast cancer awareness month.’ This is in a bid to create awareness worldwide.

According to the National Cancer Institute, Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.

When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors. Many cancers form solid tumors, which are masses of tissue.

Cancers of the blood, such as leukemias, generally do not form solid tumors. Cancerous tumors are malignant, which means they can spread into, or invade nearby tissues. In addition, as these tumors grow, some cancer cells can break off and travel to distant places in the body through the blood or the lymph system and form new tumors far from the original tumor. Unlike malignant tumors, benign tumors do not spread into, or invade nearby tissues. Benign tumors can sometimes be quite large. When removed, they usually don’t grow back, but malignant tumors do.

According to research, each cancer is thought to first start from one abnormal cell. What happens is that certain vital genes that control how cells divide and multiply are damaged or altered. This makes the cell abnormal. If the abnormal cell survives it may multiply out of control into a cancerous (malignant) tumor.

Experts say we all have a risk of developing cancer. Many cancers seem to develop for no apparent reason; certain risk factors are known to increase the chance that one or more of your cells will become abnormal and lead to cancer. Risk factors include the following: lifestyle e.g. smoking, lack of physical activity; diets, certain types of infections; such as human papillomaviruses, HPV, Helicobacter pylori, and hepatitis B, HBV, and hepatitis C viruses, HCV, and environmental exposures to different types of chemicals and radiation.

The NSIA-LUTH Cancer Centre which was commissioned recently by President Muhammadu Buhari opened for patients on May 1. The ultra-modern equipment has undergone the necessary calibrations and fine-tuned to comply with international standards before going to operate. “The rigorous steps are a must before international and local regulatory bodies can certify any high-end irradiating equipment for use on patients,” the CMD, Prof. Chris Bode said.

He also disclosed that the center, financed by the Nigeria Sovereign Investment Authority, NSIA, is designed in compliance with international best practices while requisite personnel including radiotherapists, oncologists, physicists, and nurses are currently undergoing conversion training in readiness for the smooth take-off of services at the center. He added that the multi-billion cancer center was established as a joint-venture partnership between the NSIA and LUTH to address the lack of adequate and comprehensive cancer treatment and management in the country.

Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy (including immunotherapy such as monoclonal antibody therapy) and synthetic lethality. The choice of therapy depends upon the location and grade of the tumor and the stage of the disease, as well as the general state of the patient (performance status). Cancer genome sequencing helps in determining which cancer the patient exactly has for determining the best therapy for cancer. A number of experimental cancer treatments are also under development. Under current estimates, two in five people will have cancer at some point in their lifetime.

Complete removal of cancer without damage to the rest of the body (that is, achieving cure with near-zero adverse effects) is the ideal goal of treatment and is often the goal in practice. Sometimes this can be accomplished by surgery, but the propensity of cancers to invade adjacent tissue or to spread to distant sites by microscopic metastasis often limits its effectiveness, and chemotherapy and radiotherapy can have a negative effect on normal cells.

Therefore, cure with non-negligible adverse effects may be accepted as a practical goal in some cases; and besides curative intent, practical goals of therapy can also include (1) suppressing cancer to a subclinical state and maintaining that state for years of good quality of life (that is, treating cancer as a chronic disease), and (2) palliative care without curative intent (for advanced-stage metastatic cancers).

Because “cancer” refers to a class of diseases, it is unlikely that there will ever be a single” cure for cancer” any more than there will be a single treatment for all infectious diseases. Angiogenesis inhibitors were once thought to have potential as a “silver bullet” treatment applicable to many types of cancer, but this has not been the case in practice.

Speaking to AljazirahNigeria, Ben Amodu said: “American scientists visited me here about five years ago in my lab, took five samples of my drugs that can treat colon cancer. I never followed them to the U.S, specifically the state of Texas. They started the analysis, first on colon cancer, and then they discovered it can treat colon cancer, and saw that it was doing very well up to 80-89 % in resolving colon cancer.

While they were doing this research, they discovered the drug could resolve lung cancer. They hurriedly set up another experiment on the product and they got 80-89% for both cancers’ I was not there. These things were reported based on scientific procedure, the discovery was presented to a gathering of 18,000 America scientists where the discovery was crowned as a lead discovery and as we speak today we are making use of that product to cure Asthma which has no cure anywhere in the world because of its effect on the lungs. Cancer of the lungs is the highest disease of the lungs, so asthma is child’s play and truly we use it on asthma patients and we’ve cured several.” This was prior to the NCI confirmation.

And for Nigerians and the world at large, the end might just be in sight for a lasting cure to Cancer, one of the leading killer diseases.

Share on Facebook

Featured

Daughters of Dr. Charles Ononiwu, Chiamanda and Chiamaka, Launch Debut Books to Uplift Hearts Facing Life’s Struggles

Published

4 weeks ago

October 10, 2025

The Gleamer

Joel Ajayi

At just 18 and 20 years old, Chiamanda and Chiamaka Ononiwu — daughters of renowned Nigerian surgeon Dr. Charles Ononiwu — have achieved a remarkable milestone with the release of their debut inspirational books, Do Not Be Afraid and Waterfalls.

Their literary journey began six years ago, during the height of the global COVID-19 pandemic. While the world was engulfed in fear and uncertainty, the then 13- and 15-year-old sisters turned inward, using writing as an outlet to process their emotions, express their faith, and reach out to others with messages of hope and resilience.

What began as a quiet act of creativity blossomed into two powerful books that now serve as beacons of light for readers navigating life’s storms.

Eighteen-year-old Chiamanda Ononiwu is the author of Do Not Be Afraid. A passionate Electrical Engineering student , she is also a proud alumna of Intellichild TLC and Valedictorian of Great Blessings School, Class of 2022.

In her book, she addresses the emotional challenges many young people face and draws from her personal faith to offer guidance and encouragement.

Her elder sister, Chiamaka Ononiwu, 20, is a final-year medical student at Babcock University in Nigeria. She penned Waterfalls, a heartfelt and deeply spiritual work she describes as divinely inspired. Chiamaka views her writing as a calling — a mission to uplift souls and bring hope to those struggling with life’s challenges.

“Personally, I would say it all started with the idea of inclusion, inspired by real human experiences,” Chiamaka shared. “We’ve had conversations with people who’ve gone through difficult situations — including issues and those stories helped shape what I write today.”

She added, “It’s all about encouraging people to face life with faith. We began this journey during a dark time in the world, and I felt called to create something that could offer comfort and hope — not just locally, but globally.”

The official book launch and signing ceremony took place on Wednesday in Abuja, Nigeria’s capital, and was attended by family, friends, colleagues, and well-wishers. It was a celebration of creativity, faith, and youthful brilliance, as the sisters presented their work to an inspired audience.

Speaking at the event, Chiamaka emphasized the core message of her book: “Waterfalls reminds readers that God is always watching over His people. He doesn’t bring fear — He brings peace, hope, and love. I want readers to find comfort and assurance in that truth.”

For Chiamanda, her book is a message to young people who may feel overwhelmed by life’s pressures: “Do Not Be Afraid is especially for youth navigating difficult times. No matter how hard life gets, you can always find strength and direction in God’s word.”

Writing came naturally to both sisters. Chiamaka recalled, “Even as a child, I loved writing short stories for my siblings. When the opportunity came to publish, I knew it was time to share my message with a wider audience.”

Despite their demanding academic paths, both young women balanced their studies with writing through perseverance and faith.

Chiamanda and Chiamaka are united by a shared dream — to inspire people across the world with their writing.

Chiamaka expressed Further; “Our biggest hope is that these books will reach people who need to know that God is real, that He’s always with them, and that through Him, anything is possible,” Chiamaka said.

With Do Not Be Afraid and Waterfalls, the Ononiwu sisters have not only created literary works — they’ve created lifelines. Their voices, grounded in faith and driven by purpose, remind readers everywhere that even in the darkest moments, God’s light never fades.

Their father, Dr. Charles Ononiwu — a distinguished surgeon and deeply devoted parent — also spoke at the event, sharing the journey from his perspective.

“For me, my number one priority has always been to care for children — not just medically, but also by encouraging them academically and in the basics of life,” he said.

He recounted a moving moment with Chiamanda, who approached him with the idea of sharing her story publicly to inspire others.

“She came to me and said she wanted to talk to her peers, to share how she had been comforted, and to help them see that everything would be okay,” he recalled. “As a father, my role was to guide her. I support both of them, help activate their strengths, and provide direction.”

Dr. Ononiwu made the decision to fund the publication of their books himself, believing in the power of their message.

“I told them, ‘You have something the world needs. You can make an impact in the lives of others,’” he said. “I believe every child has a gift. It is our responsibility as parents not to dismiss them, but to help them discover and nurture their talents.”

He encouraged all parents to support their children’s creative pursuits, noting, “Every person has something special inside them — no one is without talent. It’s just a matter of looking inward, discovering that gift, and sharing it with the world.”

Share on Facebook